Lobeline Attenuates the Locomotor-Activating Properties of Repeated Morphine Treatment in Rats

DK Miller, JE Polston, KR Rodvelt, MJ Will
2011 Tropical Journal of Pharmaceutical Research  
Purpose: Lobeline perturbs intra-and extracellular neurotransmitter levels and diminishes the in vitro and in vivo effects of psychostimulants. More recently, lobeline was shown to bind to µ opiate receptors, block the effects of opiate receptor agonists, and decrease heroin self-administration in rats. The present study determined the effect of lobeline on morphine-induced changes in locomotor behavior in rats. Methods: For 12 consecutive days (Days 1 -12), male rats were administered lobeline
more » ... ministered lobeline (0.3 or 1 mg/kg) followed by morphine (5 or 10 mg/kg) and locomotor activity was measured. On Day 13, the effect of lobeline on the expression of morphine-induced increases in activity was determined. Results: With repeated morphine treatment, an increase in locomotor activity was observed. In a dosedependent manner, lobeline decreased the morphine-induced increase in activity. Acute lobeline challenge on Day 13 also attenuated the expression of this morphine-induced increase in activity. Conclusion: These results are consistent with previous work where lobeline blocks the locomotoractivtating properties of psychostimulants, and these findings support an emerging literature suggesting that lobeline produces its behavioral effects through an interaction with µ opiate receptors.
doi:10.4314/tjpr.v10i4.7 fatcat:gqy5hmgjpnekxfpazockjxcrji